Reported Reactions

Devices › Implant, endosseous, root-form

Device brand name · Endosseous dental implant

BLT ?4.8mm RC, SLA? 8mm, Ti, Loxim: medical device reports filed with FDA

15,574 reports name it, 2019–2026. Manufacturer given most often on reports: Institut Straumann. Product code DZE.

15,574
device reports naming the brand
0.1% of all MAUDE reports · about 2,281 a year
6,187
reports, 12 months to August 2026
4,570 in the 12 months before
0%
classified as malfunction
0.8% across the product code
0%
classified as death, as reported
0 reports · not verified by FDA

FDA's MAUDE database holds 15,574 reports that name the brand "BLT ?4.8mm RC, SLA? 8mm, Ti, Loxim" (endosseous dental implant), received between September 2019 and August 2026; the manufacturer given most often on reports is Institut Straumann. Spellings of one product vary from report to report.

6,187 reports arrived in the 12 months to August 2026, up 35% from 4,570 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (100%); across all implant, endosseous, root-form reports (product code DZE) death is recorded in 0% and malfunction in 0.8%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are failure to osseointegrate (92.8%), loss of osseointegration (6.4%) and fracture (0.2%). The patient problems coded most often are fibrosis, pain and inflammation. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

06381,275Sep 2021: 27Oct 2021: 46Nov 2021: 21Dec 2021: 322022Jan 2022: 42Feb 2022: 43Mar 2022: 55Apr 2022: 64May 2022: 42Jun 2022: 27Jul 2022: 53Aug 2022: 45Sep 2022: 48Oct 2022: 84Nov 2022: 95Dec 2022: 512023Jan 2023: 52Feb 2023: 36Mar 2023: 40Apr 2023: 102May 2023: 90Jun 2023: 147Jul 2023: 172Aug 2023: 156Sep 2023: 183Oct 2023: 161Nov 2023: 200Dec 2023: 2152024Jan 2024: 224Feb 2024: 230Mar 2024: 164Apr 2024: 349May 2024: 242Jun 2024: 287Jul 2024: 256Aug 2024: 268Sep 2024: 338Oct 2024: 159Nov 2024: 292Dec 2024: 3802025Jan 2025: 311Feb 2025: 205Mar 2025: 242Apr 2025: 254May 2025: 0Jun 2025: 1,275Jul 2025: 411Aug 2025: 703Sep 2025: 791Oct 2025: 385Nov 2025: 640Dec 2025: 5952026Jan 2026: 536Feb 2026: 497Mar 2026: 300Apr 2026: 381May 2026: 342Jun 2026: 657Jul 2026: 508Aug 2026: 555

Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

By year received

02,9065,8122019: 8520192020: 15320202021: 35620212022: 64920222023: 1,55420232024: 3,18920242025: 5,81220252026: 3,7762026

Event type and report source

Event type, as classified on the report

Death0%0
Injury100%15,574
Malfunction0%0
Other0%0
Not given0%0

Who filed the report

Manufacturer report97.7%15,221
Voluntary report0%0
User facility report0%0
Distributor report2.3%353
Not given0%0

Grey bar: all 3,924,241 reports carrying product code DZE. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Failure to osseointegrate14,44992.8%62.8%
Loss of osseointegration9956.4%22.4%
Fracturea broken bone260.2%1.6%
Difficult to insertthe device was hard to insert210.1%0.4%
Separation failure40%0.1%
Activation, positioning or separation problem10%0%
Unintended movement10%0%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Fibrosis2,44715.7%
Painpain, site not specified1,5079.7%
Inflammationinflammation8025.1%
Swelling/ edema7965.1%
Hemorrhage/blood loss/bleeding2891.9%
Tissue damage1501%
Numbnessnumbness1140.7%
Abscessa collection of pus820.5%
Fistula620.4%
Hyperresponsive to stimuli510.3%
Hypersensitivity/allergic reaction220.1%
Sinus perforation190.1%
Swellingswelling140.1%
Failure of implant80.1%
Inadequate osseointegration40%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureBLT ?4.8mm RC, SLA? 8mm, Ti, LoximProduct code DZEAll MAUDE reports
Reports15,5743,924,24126,136,888
Share of that pool—0.4%0.1%
Classified as death, per 1,000 reports009
Classified as injury100%99.2%36.2%
Classified as malfunction0%0.8%62.3%
Filed by the manufacturer97.7%77.7%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code DZE

BrandReportsLatest 12 monthsClassified as death
Biohorizons Dental Implant58,73200%
BioHorizons Inc.57,02025,5360%
NobelActive Internal RP 4.3x10mm49,0989,5280%
BLT ?4.1mm RC, SLA? 10mm, TiZr, Loxim45,6509,6770%
NobelParallel CC RP 4.3x10mm44,2699,3180%
BLT ?4.1mm RC, SLActive? 10mm, TiZr, NTP41,6727,5310%
Unknown Implant39,9671,4540%
NobelReplace CC RP 4.3x10mm35,9468,1660%
NobelReplace CC PMC RP 4.3x10mm34,4478,6900%
NobelActive Internal RP 4.3x11.5mm33,1175,7040%
BLT ?3.3mm NC, SLA? 10mm, TiZr, Loxim28,6485,6950%
BLT ?4.1mm RC, SLA? 10mm, Ti, Loxim26,7248,4810%
BLT ?3.3mm NC, SLActive? 10mm, TiZr, NTP26,5404,6800%
NobelActive Internal RP 4.3x13mm25,5563,7640%
BLT ?4.1mm RC, SLA? 8mm, TiZr, Loxim24,7725,9780%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about BLT ?4.8mm RC, SLA? 8mm, Ti, Loxim reports

How many FDA reports name BLT ?4.8mm RC, SLA? 8mm, Ti, Loxim?

15,574 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 6,187 in the latest 12 months.

What kinds of events are reported?

injury (100%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

failure to osseointegrate (92.8%), loss of osseointegration (6.4%), fracture (0.2%), difficult to insert (0.1%) and separation failure (0%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (97.7%) and distributor reports (2.3%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that BLT ?4.8mm RC, SLA? 8mm, Ti, Loxim was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.